Union Minister of Health and Family Welfare, Jagat Prakash Nadda, will launch Indian Pharmacopoeia 2026 in the first week of January 2026. 

Nadda appreciated IPC’s sustained efforts in strengthening pharmacopoeial standards and pharmacovigilance activities, which contribute to the Government’s vision of Atmanirbhar Bharat and a Viksit Bharat, promoting self-reliance, scientific excellence, and robust healthcare standards. 

Union Minister of Health and Family Welfare, Jagat Prakash Nadda, reviewed the progress and initiatives of the Indian Pharmacopoeia Commission (IPC), in the presence of Nivedita Shukla Verma, Secretary, Department of Chemicals and Petrochemicals (DCPC) and holding additional charge as Secretary, Ministry of Health and Family Welfare.   

During the review, Nadda commended IPC for its pivotal role in ensuring the quality, safety, and efficacy of medicines, thereby protecting public health. He noted that the Indian Pharmacopoeia remains a critical scientific and regulatory reference, ensuring uniform standards of medicines across the country.  

The Minister highlighted that “Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities.”  

He observed that “This recognition strengthens India’s position as the Pharmacy of the World and underscores the credibility of Indian pharmacopoeial standards globally.” 

In the meeting, Nadda emphasized IPC’s crucial role in implementing the Pharmacovigilance Programme of India (PvPI) to monitor adverse drug reactions and ensure patient safety, and appreciated its efforts to strengthen reporting systems and build capacity among healthcare professionals. He also lauded IPC’s contribution to Atmanirbhar Bharat. 

The Minister encouraged IPC to continue focusing on innovation, digitalisation, and global harmonisation of standards in line with the vision of Viksit Bharat, to ensure universal access to safe and quality medicines.  

The details of the activities were presented by Dr. V. Kalaiselvan, Secretary-cum-Scientific Director (IPC) and he further reaffirmed the commitment to further strengthen pharmacopoeial and pharmacovigilance standards, enhancing international collaboration and contributing to national and global health objectives. 

Harsh Mangla, Joint Secretary, MoHFW and other senior officers of the Ministry were also present at the meeting.